117 related articles for article (PubMed ID: 5757971)
1. [Hormone treatment of breast cancer in the advanced phase].
Demol R
Brux Med; 1968 Oct; 48(10):665-9. PubMed ID: 5757971
[No Abstract] [Full Text] [Related]
2. Teslac.
Med Lett Drugs Ther; 1970 May; 12(11):45-6. PubMed ID: 4935986
[No Abstract] [Full Text] [Related]
3. [A method of testing the antitumor effectiveness of drugs on induced rat mammary gland cancer].
Beskrovnyĭ AM
Vopr Onkol; 1970; 16(8):62-6. PubMed ID: 5501884
[No Abstract] [Full Text] [Related]
4. Observations on the hormone sensitivity of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors in the Sprague-Dawley rat.
Griswold DP; Green CH
Cancer Res; 1970 Mar; 30(3):819-26. PubMed ID: 5463906
[No Abstract] [Full Text] [Related]
5. Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.
Talley RW; O'Bryan RM; Burrows JH; San Diego EL
Cancer Chemother Rep; 1970 Aug; 54(4):249-53. PubMed ID: 4946009
[No Abstract] [Full Text] [Related]
6. Towards a new chemotherapy for endometriosis: an experimentalist's perspective.
Matsumura KN
Exp Med Surg; 1970; 28(1):18-23. PubMed ID: 5508496
[No Abstract] [Full Text] [Related]
7. Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
Keating JL; Yonemoto RH; Byron RL
Surg Gynecol Obstet; 1968 Sep; 127(3):538-42. PubMed ID: 4969618
[No Abstract] [Full Text] [Related]
8. Comparison of testosterone decanoate, drostanolone and testololactone in disseminated breast cancer--a randomized clinical study.
Rieche K; Wolff G
Arch Geschwulstforsch; 1975; 45(5):485-8. PubMed ID: 1243528
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of metastasizing breast cancer with anabolic steroids].
Hortling H; Malmio K
Nord Med; 1967 Mar; 77(9):275-9. PubMed ID: 6020758
[No Abstract] [Full Text] [Related]
10. [Calusterone (7-beta, 17-alpha-dimethyltestosterone) in the palliative treatment of advanced breast cancer].
Robustelli Della Cuna G; Bernardo G; Strada MR
Minerva Med; 1977 Oct; 68(52):3555-63. PubMed ID: 74052
[TBL] [Abstract][Full Text] [Related]
11. [HORMONE TREATMENT OF BREAST CANCER IN THE ADVANCED PHASE. COMPARISON BETWEEN TESTOSTERONE PROPIONATE AND THE TESTOSTERONE-DELTA-1-TESTOLOLACTONE COMBINATION].
ROYER P; DELAITRE R; MATHIEU H; GABILAN JC; RAYNAUD C; PASQUALINI JR; DEBRIS P; GERBEAUX S; HABIB R
Rev Fr Etud Clin Biol; 1964 Jan; 9():88-90. PubMed ID: 14129164
[No Abstract] [Full Text] [Related]
12. [Effects of the therapy combined with oophorectomy for the advanced breast cancer].
Shinoda M; Oka T
Gan No Rinsho; 1971; 17(9):670-5. PubMed ID: 5165861
[No Abstract] [Full Text] [Related]
13. Testolactone aqueous suspension (Teslac).
Clin Pharmacol Ther; 1970; 11(2):302-6. PubMed ID: 5416857
[No Abstract] [Full Text] [Related]
14. [COMPARATIVE METHODICAL STUDY OF TESTOSTERONE PROPIONATE AND DELTA-1-TESTOLACTONE IN THE TREATMENT OF ADVANCED BREAST CANCER. PERSONAL EXPERIENCE WITHIN THE "EUROPEAN BREAST CANCER GROUP"].
NETTER A; GORINS A
Bull Mem Soc Med Hop Paris; 1963 Jun; 114():957-65. PubMed ID: 14074196
[No Abstract] [Full Text] [Related]
15. [Chemical adrenalectomy--a new alternative in the treatment of advanced breast cancer].
Wilking N; Appelgren LE; Carlström K; Wallgren A; Theve T
Lakartidningen; 1983 Jun; 80(26-27):2644-5. PubMed ID: 6621193
[No Abstract] [Full Text] [Related]
16. Antifracture efficacy of long-term estrogens for osteoporosis.
Gordan GS; Picchi J; Roof BS
Trans Assoc Am Physicians; 1973; 86():326-32. PubMed ID: 4363387
[No Abstract] [Full Text] [Related]
17. The role of androgens and anabolic steroids in the treatment of cancer.
Brodsky I
Semin Drug Treat; 1973; 3(1):15-25. PubMed ID: 4740371
[No Abstract] [Full Text] [Related]
18. [Experiences with hormone therapy and with the prevention of generalization of breast cancer].
Holecek V; Lhotka J; Borek Z
Sb Lek; 1967 Aug; 69(8):243-50. PubMed ID: 6077250
[No Abstract] [Full Text] [Related]
19. [THE HORMONAL TREATMENT OF ADVANCED BREAST CANCER. STUDY METHODS: COMPARISON OF DELTA-1-TESTOLOLACTONE WITH TESTOSTERONE PROPIONATE].
VANRYMENANT M; COUNE A; TAGNON HJ; SIMON S
Acta Clin Belg; 1963; 18():469-79. PubMed ID: 14110611
[No Abstract] [Full Text] [Related]
20. [Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Horton J; Olson K
Poumon Coeur; 1968; 24(1):59-62. PubMed ID: 4968016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
